Rhumbline Advisers Acquires 8,299 Shares of Rocket Pharmaceuticals, Inc. (NASDAQ:RCKT)
Rhumbline Advisers lifted its holdings in Rocket Pharmaceuticals, Inc. (NASDAQ:RCKT – Free Report) by 8.4% in the first quarter, Holdings Channel reports. The fund owned 107,638 shares of the biotechnology company’s stock after purchasing an additional 8,299 shares during the quarter. Rhumbline Advisers’ holdings in Rocket Pharmaceuticals were worth $718,000 at the end of the […]
